Menu
Not yet recruiting NCT06744803

The Effect of a Gamified Neuropathy Management Application on Cancer Behavior in Cancer Patients Undergoing Chemotherapy

No phase Interventional Cancer Chemotherapy Induced Pain Neuropathy Nursing Gamification

For patients and families

In plain language

Fill the application

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Gamified Neuropathy Management Application on Cancer Behavior.
Who it may be relevant to
Registry conditions: Cancer, Chemotherapy Induced Pain Neuropathy, Nursing, Gamification. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

The Effect of a Gamified Neuropathy Management Application on Cancer Behavior in Cancer Patients Undergoing Chemotherapy: A Prospective Follow-Up Study

Overview

This study will be conducted to determine the effect of a gamified neuropathy management application on cancer behavior in cancer patients undergoing chemotherapy.

Detailed description

Cancer patients may experience treatment-related issues throughout their treatment process. Chemotherapy-induced peripheral neuropathy is one of the symptoms that negatively affects patients' overall health status. Peripheral neuropathy can occur during or after chemotherapy, leading to sensory, motor, and autonomic nerve damage. It is particularly common among cancer patients receiving taxane- and platinum-based chemotherapy.

Effective management of neuropathy is a crucial aspect of nursing care. Here are some key points regarding this issue: pharmacological and non-pharmacological methods, lifestyle control, and nursing interventions are employed. The management of peripheral neuropathy can have a significant impact on the overall health and well-being of cancer patients undergoing chemotherapy. Nurses play a vital role in this process by providing support that enhances patients' quality of life and improves treatment outcomes.

Gamification applications, which have recently started to be used in patient education, represent a contemporary approach. However, no studies have been found utilizing gamification specifically in patient education for cancer. For this reason, this study aims to contribute to patients' neuropathy management using a gamification application.

Interventions

  • Behavioral Gamified Neuropathy Management Application on Cancer Behavior
    The study will be conducted in three phases: Phase 1: The content of the gamified neuropathy management application used in the study will be prepared by the researchers using relevant literature. Phase 2: The developed gamified neuropathy management application will be introduced to patients during one-on-one interviews at the daytime chemotherapy clinic. After collecting pre-test data, the application will be sent to the patients, who will be asked to use it for 8 weeks. Phase 3: Following

Primary outcome measures

  • The effect of gamified neuropathy management application on chemotherapy-associated peripheral neuropathic pain. [Time frame: 6 months]
  • The effect of gamified neuropathy management application on chemotherapy-associated peripheral neuropathic level [Time frame: 6 months]
  • The effect of gamified neuropathy management application on cancer behaviour [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • Undergoing chemotherapy treatment and have completed their first cycle.
  • Literate (able to read and write).
  • Able to use a smartphone.
  • Aged between 18 and 65 years.
  • Willing to participate in the study voluntarily.

Exclusion criteria

  • Participants who do not use the application during the study period
  • Participants who fail to complete the data collection forms

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

Turkey (Türkiye) · 1 center
  • Ankara Yıldırım Beyazit University — Ankara

Identifiers

NCT: NCT06744803 · 01.08.2024/78 KARAR NO:36

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗